Articles

Aggressive Approach to High-Risk Smoldering Myeloma Gains Consensus

By Patricia Stewart

TON - December 2020, Vol 13, No 6

Explosion of New Regimens for Multiple Myeloma: Selecting the Right Option for the Right Patient

By Patricia Stewart

TON - December 2020, Vol 13, No 6

At the National Comprehensive Cancer Network 2020 Virtual Congress: Hematologic Malignancies, multiple myeloma expert Shaji Kumar, MD, discussed the “bonanza of treatment regimens for multiple myeloma.” Although several new treatments and combination regimens have extended survival in patients with multiple myeloma, this cancer remains an incurable chronic disease, he said. Read More ›

Novel Drug Combinations Achieving Undetectable Minimal Residual Disease in Patients with CLL

By William King

TON - December 2020, Vol 13, No 6

Nivolumab New Standard of Care in Gastroesophageal Cancers as First-Line or Adjuvant Therapy

By Patricia Stewart

ESMO, ESMO 2020

TON - December 2020, Vol 13, No 6

Cabozantinib plus Nivolumab Offers New First-Line Treatment Option for Patients with Advanced Renal-Cell Carcinoma

By Patricia Stewart

ESMO, ESMO 2020

TON - December 2020, Vol 13, No 6

Olaparib Significantly Improves Survival in Men with Metastatic Prostate Cancer and BRCA Mutations

By Patricia Stewart

ESMO, ESMO 2020

TON - December 2020, Vol 13, No 6

“Practice-Changing” Results Seen with Adjuvant Abemaciclib plus Endocrine Therapy in HR-Positive, HER2-Negative Breast Cancer

By Patricia Stewart

ESMO, ESMO 2020

TON - December 2020, Vol 13, No 6

Opportunities for Innovation in Value-Based Payments in Oncology

Value-Based Care

TON - December 2020, Vol 13, No 6

Can We Lower the Cost of Cancer Care?

Value-Based Care

TON - December 2020, Vol 13, No 6

Personalized Vaccine plus Atezolizumab Shows Promising Clinical Activity in Advanced Cancer

By Patricia Stewart

TON - December 2020, Vol 13, No 6

Page 107 of 376

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

TON Print Edition

TON Weekly e‑Newsletter

I have reviewed and consent to the terms of TON's Privacy Policy, and TON has my permission to retain my information in its database, and to forward pertinent communications to me.